Appropriateness of imaging for lung cancer staging in a national cohort

Journal of Clinical Oncology

Volumn 32, Issue 30, 2014, Pages 3428-3435

  Backhus, Leah M ^a,b   Farjah, Farhood ^b   Varghese, Thomas K ^b   Cheng, Aaron M ^b   Zhou, Xiao Hua ^a   Wood, Douglas E ^b   Kessler, Larry ^b   Zeliadt, Steven B ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; UNITED STATES; BONE; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

ADULT; AGED; BONE AND BONES; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY;

EID: 84908399050     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.55.6589     Document Type: Article

References (40)

1. Dinan MA, Curtis LH, Carpenter WR, et al: Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007. Radiology 267:807-817, 2013
2. Dinan MA, Curtis LH, Hammill BG, et al: Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA 303:1625-1631, 2010
3. Hu YY, Kwok AC, Jiang W, et al: High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst 104:1164-1172, 2012
4. Mariotto AB, Yabroff KR, Shao Y, et al: Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103:117-128, 2011
5. Warren JL, Yabroff KR, Meekins A, et al: Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst 100:888-897, 2008
6. Welch HG, Hayes KJ, Frost C: Repeat testing among Medicare beneficiaries. Arch Intern Med 172:1745-1751, 2012
7. Baker L, Birnbaum H, Geppert J, et al: The relationship between technology availability and health care spending. Health Aff (Millwood) W3-537-51, 2003
8. National Comprehensive Cancer Network (NCCN): NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, version 4.2014
9. Ravenel JG, Mohammed TL, Movsas B, et al: ACR Appropriateness Criteria noninvasive clinical staging of bronchogenic carcinoma. J Thorac Imaging 25:W107-W111, 2010
10. Fischer B, Lassen U, Mortensen J, et al: Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:32-39, 2009
11. National Comprehensive Cancer Network (NCCN): NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer version 2.2010
12. Quan H, Sundararajan V, Halfon P, et al: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130-1139, 2005
13. Klabunde CN, Legler JM, Warren JL, et al: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17:584-590, 2007
14. Elixhauser A, Steiner C, Palmer L: Clinical Classifications Software (CCS), US Agency for Healthcare Research and Quality, 2010
15. Cerfolio RJ, Ojha B, Bryant AS, et al: The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 78:1017-1023, 2004
16. Silvestri GA, Gould MK, Margolis ML, et al: Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132:178S-201S, 2007
17. Silvestri GA, Gonzalez AV, Jantz MA, et al: Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed-American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e211S-e250S, 2013
18. Reed CE, Harpole DH, Posther KE, et al: Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable nonsmall cell lung cancer. J Thorac Cardiovasc Surg 126:1943-1951, 2003
19. Onega T, Tosteson TD, Wang Q, et al: Geographic and sociodemographic disparities in PET use by Medicare beneficiaries with cancer. J Am Coll Radiol 9:635-642, 2012
20. Hsia TC, Shen YY, Yen RF, et al: Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 49:267-271, 2002
21. Gayed I, Vu T, Johnson M, et al: Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 5:26-31, 2003
22. Cheran SK, Herndon JE 2nd, Patz EF Jr: Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 44:317-325, 2004
23. Roberts CC, Daffner RH, Weissman BN, et al: ACR appropriateness criteria on metastatic bone disease. J Am Coll Radiol 7:400-409, 2010
24. Colice GL, Birkmeyer JD, Black WC, et al: Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest 108:1264-1271, 1995
25. Cole FH Jr, Thomas JE, Wilcox AB, et al: Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: Is it worthwhile? Ann Thorac Surg 57:838-840, 1994
26. Yohena T, Yoshino I, Kitajima M, et al: Necessity of preoperative screening for brain metastasis in nonsmall cell lung cancer patients without lymph node metastasis. Ann Thorac Cardiovasc Surg 10:347-349, 2004
27. Lysdahl KB, Børretzen I: Geographical variation in radiological services: A nationwide survey. BMC Health Serv Res 7:21, 2007
28. Saigal CS, Pashos CL, Henning JM, et al: Variations in use of imaging in a national sample of men with early-stage prostate cancer. Urology 59:400-404, 2002
29. Komaki R, Khalid N, Langer CJ, et al: Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: A quality research in radiation oncology survey. Int J Radiat Oncol Biol Phys 85:1082-1089, 2013
30. Center for Medicare and Medicaid Services: Medicare Hospital Outpatient Prospective Payment System (HOPPS) (APC) CY 2014 Final Rule (Fed. Reg. Version add B), 2014. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFSFederal-Regulation-Notices-Items/CMS-1600-FC.html
31. Crivello ML, Ruth K, Sigurdson ER, et al: Advanced imaging modalities in early stage breast cancer: Preoperative use in the United States Medicare population. Ann Surg Oncol 20:102-110, 2013
32. Burke JF, Kerber KA, Iwashyna TJ, et al: Wide variation and rising utilization of stroke magnetic resonance imaging: Data from 11 states. Ann Neurol 71:179-185, 2012
33. Coburn N, Przybysz R, Barbera L, et al: CT, MRI and ultrasound scanning rates: Evaluation of cancer diagnosis, staging and surveillance in Ontario. J Surg Oncol
34. Coburn N, Przybysz R, Barbera L, et al: Evaluation of CT and MRI scanning among cancer patients in Ontario. Clin Imaging 35:301-308, 2011
35. Breslin TM, Banerjee M, Gust C, et al: Trends in advanced imaging use for women undergoing breast cancer surgery. Cancer 119:1251-1256, 2013
36. Srygley FD, Abbott DH, Grambow SC, et al: Variability in resource use: Diagnosing colorectal cancer. Am J Manag Care 19:370-376, 2013
37. Farjah F, Flum DR, Ramsey SD, et al: Multimodality mediastinal staging for lung cancer among Medicare beneficiaries. J Thorac Oncol 4:355-363, 2009
38. McWhirter E, Yogendran G, Wright F, et al: Baseline radiological staging in primary breast cancer: Impact of educational interventions on adherence to published guidelines. J Eval Clin Pract 13:647-650, 2007
39. Blackmore CC, Mecklenburg RS, Kaplan GS: Effectiveness of clinical decision support in controlling inappropriate imaging. J Am Coll Radiol 8:19-25, 2011
40. Cassel CK, Guest JA: Choosing wisely: Helping physicians and patients make smart decisions about their care. JAMA 307:1801-1802, 2012